H. J. C. SWAN, M.D., Ph.D.; KANU CHATTERJEE, M.D.; ELIOT CORDAY, M.D.; WILLIAM GANZ, M.D.; HAROLD MARCUS, M.D.; JACK MATLOFF, M.D.; WILLIAM PARMLEY, M.D.
Myocardial revascularization is ideally indicated for critical obstructive lesions in the proximal portions of the coronary vessel, particularly in the left coronary system, with minimally involved distal vessels. Two conditions indicate a serious deficiency in coronary blood supply: severe, disabling, intractable angina pectoris and unstable angina pectoris. The overall operative mortality rate is 7%, including patients with complications of myocardial ischemia (infarction, ventricular aneurysm); in "uncomplicated" symptomatic cases a rate of 3% should be attained. After successful revascularization of the myocardium, with a functioning vein graft and no postoperative myocardial damage, we have shown improved ventricular function. Patients with enlarged hearts with little or no angina, patients with distal as opposed to proximal obstructive disease, and patients with diffuse or localized myocardial scarring are not accepted for surgery.
SWAN HJC, CHATTERJEE K, CORDAY E, GANZ W, MARCUS H, MATLOFF J, et al. Myocardial Revascularization for Acute and Chronic Coronary Heart Disease. Ann Intern Med. ;79:851–866. doi: 10.7326/0003-4819-79-6-851
Download citation file:
Published: Ann Intern Med. 1973;79(6):851-866.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use